By performing both in vitro and in vivo assay, we hypothesized that overexpression of FAM46A may confers chemo-resistance to ovarian carcinoma by regulating aberrant activation of the TGF-β signaling pathway. The gene discussed is TENT5A; the disease is ovarian carcinoma.